13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000950123-23-005321
Total Value
$800,117
Positions
34
Other Managers
11
Confidential Omitted
No
Holdings (34)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 8,300,000 | $110,058 | 13.76% |
| 2 | NUVALENT INC | NUVL | 3,577,267 | $93,331 | 11.66% |
| 3 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 3,081,307 | $79,313 | 9.91% |
| 4 | DISC MEDICINE INC | IRON | 1,990,914 | $42,187 | 5.27% |
| 5 | NATERA INC | NTRA | 700,197 | $38,875 | 4.86% |
| 6 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 3,915,000 | $38,406 | 4.80% |
| 7 | CRINETICS PHARMACEUTICALS IN | CRNX | 2,305,558 | $37,027 | 4.63% |
| 8 | MERSANA THERAPEUTICS INC | 59045L106 | 8,663,673 | $35,608 | 4.45% |
| 9 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 3,000,000 | $33,000 | 4.12% |
| 10 | ACLARIS THERAPEUTICS INC | ACRS | 3,400,000 | $27,506 | 3.44% |
| 11 | PHARVARIS N V | PHVS | 3,180,601 | $25,620 | 3.20% |
| 12 | SAVARA INC | SVRA | 11,622,598 | $22,664 | 2.83% |
| 13 | CYMABAY THERAPEUTICS INC | 23257D103 | 2,500,000 | $21,800 | 2.72% |
| 14 | CTI BIOPHARMA CORP | 12648L601 | 4,702,996 | $19,753 | 2.47% |
| 15 | EQRX INC | 26886C107 | 10,003,573 | $19,407 | 2.43% |
| 16 | ANNEXON INC | ANNX | 4,886,616 | $18,813 | 2.35% |
| 17 | NURIX THERAPEUTICS INC | NRIX | 1,822,883 | $16,187 | 2.02% |
| 18 | SOLID BIOSCIENCES INC | SLDB | 3,130,422 | $14,838 | 1.85% |
| 19 | 2SEVENTY BIO INC | 901384107 | 1,408,901 | $14,371 | 1.80% |
| 20 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $11,049 | 1.38% |
| 21 | CARA THERAPEUTICS INC | 140755109 | 2,204,449 | $10,824 | 1.35% |
| 22 | X4 PHARMACEUTICALS INC | XFOR | 12,202,510 | $10,616 | 1.33% |
| 23 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 1,431,058 | $9,874 | 1.23% |
| 24 | XILIO THERAPEUTICS INC | XLO | 2,805,413 | $8,893 | 1.11% |
| 25 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $8,327 | 1.04% |
| 26 | TANGO THERAPEUTICS INC | TNGX | 1,921,790 | $7,591 | 0.95% |
| 27 | SYROS PHARMACEUTICALS INC | 87184Q206 | 2,124,694 | $5,673 | 0.71% |
| 28 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 2,000,000 | $5,540 | 0.69% |
| 29 | C4 THERAPEUTICS INC | CCCC | 1,642,210 | $5,157 | 0.64% |
| 30 | THIRD HARMONIC BIO INC | 88427A107 | 640,631 | $2,639 | 0.33% |
| 31 | INVIVYD INC | IVVD | 1,937,207 | $2,325 | 0.29% |
| 32 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 5,347,689 | $1,551 | 0.19% |
| 33 | APTINYX INC | 03836N103 | 8,891,758 | $1,110 | 0.14% |
| 34 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $184 | 0.02% |